Artificially Sweetened Beverages and Alzheimer Risk

Artificially sweetened beverages (with different kinds of sweeteners) could be responsible for increased cerebrovascular risk and close to a 3-fold increase in dementia risk due to Alzheimer’s disease.

Bebidas azucaradas y con edulcorante asociadas a eventos cardiovasculares y mortalidad

Both sweet and artificially sweetened drinks have been associated with cardiometabolic, cerebrovascular and dementia risk. This study prospectively evaluated sweet and sweetened beverage consumption in relation to the events above mentioned in the Framingham community. 

2888 participants over 45 years old were studied to assess the incidence of stroke and 1484 participants over 60 were studied to assess the incidence of dementia. 


Lea también: Bebidas azucaradas y con edulcorante asociadas a eventos cardiovasculares y mortalidad.


The number of drinks was measured using different specific questionnaires bearing in mind both recent and cumulative consumption in the 10-year follow-up. 

After adjusting for age, sex, education (to analyze dementia) calory intake, diet quality, physical activity and tobacco consumption, it was observed that high recent consumption and high cumulative consumption both increased the risk of stroke, any dementia and Alzheimer’s disease. 

When comparing to 0 consumption (as reference) the risk with sweetened beverages was nearly 3 times higher for stroke (HR 2.96 CI 95%, 1.26 to 6.97) and Alzheimer’s (HR 2.89 CI 95%, 1.18 to 7.07). 


Read also: Primary Prevention Guidelines Published for the First Time: Are They Useful for All Patients?


Beverages with natural sugar were not associated to stroke or dementia. 

All this information is contradicting and there are other studies with literally opposite results. The problem is randomizing and, even though multiple adjustments are made, there might be variables out of control. On example could be that the populations at higher risk of events (obesity and diabetes) consume more artificially sweetened beverages and therefore beverages wouldn’t be the cause behind events, but the baseline risk of this population. 

2020-01-14-pase2019

Original Title: Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia. A Prospective Cohort Study.

Reference: Matthew P. Pase et al. Stroke. 2017;48:1139-1146.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....